Medical Progress: Recent Advances in Neuroblastoma.

被引:1512
作者
Maris, John M. [1 ,2 ]
机构
[1] Univ Penn, Childrens Hosp Philadelphia, Div Oncol, Ctr Childhood Canc Res,Sch Med, Philadelphia, PA 19104 USA
[2] Abramson Family Canc Res Inst, Philadelphia, PA USA
关键词
HIGH-RISK NEUROBLASTOMA; CHILDRENS ONCOLOGY GROUP; AUTOLOGOUS BONE-MARROW; BLASTOMA CELLS-INVITRO; HUMAN NEURO-BLASTOMA; EVENT-FREE SURVIVAL; PHASE-II; REFRACTORY NEUROBLASTOMA; SPONTANEOUS REGRESSION; MONOCLONAL-ANTIBODY;
D O I
10.1056/NEJMra0804577
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2202 / 2211
页数:10
相关论文
共 69 条
[1]  
Asgharzadeh S, 2006, JNCI-J NATL CANCER I, V98, P1193, DOI 10.1093/jnci/djj330
[2]  
BARKER E, 1993, CANCER RES, V53, P362
[3]   Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force [J].
Beiske, K. ;
Burchill, S. A. ;
Cheung, I. Y. ;
Hiyama, E. ;
Seeger, R. C. ;
Cohn, S. L. ;
Pearson, A. D. J. ;
Matthay, K. K. .
BRITISH JOURNAL OF CANCER, 2009, 100 (10) :1627-1637
[4]   Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial [J].
Berthold, F ;
Boos, J ;
Burdach, S ;
Erttmann, R ;
Henze, G ;
Hermann, J ;
Klingebiel, T ;
Kremens, B ;
Schilling, FH ;
Schrappe, M ;
Simon, T ;
Hero, B .
LANCET ONCOLOGY, 2005, 6 (09) :649-658
[5]   An efficient targeted radiotherapy/gene therapy strategy utilising human tetomerase promoters and radioastatine and harnessing radiation-mediated bystander effects [J].
Boyd, M ;
Mairs, RJ ;
Keith, WN ;
Ross, SC ;
Welsh, P ;
Akabani, G ;
Owens, J ;
Vaidyanathan, G ;
Carruthers, R ;
Dorrens, J ;
Zalutsky, MR .
JOURNAL OF GENE MEDICINE, 2004, 6 (08) :937-947
[6]   AMPLIFICATION OF N-MYC IN UNTREATED HUMAN NEUROBLASTOMAS CORRELATES WITH ADVANCED DISEASE STAGE [J].
BRODEUR, GM ;
SEEGER, RC ;
SCHWAB, M ;
VARMUS, HE ;
BISHOP, JM .
SCIENCE, 1984, 224 (4653) :1121-1124
[7]   REVISIONS OF THE INTERNATIONAL CRITERIA FOR NEUROBLASTOMA DIAGNOSIS, STAGING, AND RESPONSE TO TREATMENT [J].
BRODEUR, GM ;
PRITCHARD, J ;
BERTHOLD, F ;
CARLSEN, NLT ;
CASTEL, V ;
CASTLEBERRY, RP ;
DEBERNARDI, B ;
EVANS, AE ;
FAVROT, M ;
HEDBORG, F ;
KANEKO, M ;
KEMSHEAD, J ;
LAMPERT, F ;
LEE, REJ ;
LOOK, AT ;
PEARSON, ADJ ;
PHILIP, T ;
ROALD, B ;
SAWADA, T ;
SEEGER, RC ;
TSUCHIDA, Y ;
VOUTE, PA .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (08) :1466-1477
[8]   Common variations in BARD1 influence susceptibility to high-risk neuroblastoma [J].
Capasso, Mario ;
Devoto, Marcella ;
Hou, Cuiping ;
Asgharzadeh, Shahab ;
Glessner, Joseph T. ;
Attiyeh, Edward F. ;
Mosse, Yael P. ;
Kim, Cecilia ;
Diskin, Sharon J. ;
Cole, Kristina A. ;
Bosse, Kristopher ;
Diamond, Maura ;
Laudenslager, Marci ;
Winter, Cynthia ;
Bradfield, Jonathan P. ;
Scott, Richard H. ;
Jagannathan, Jayanti ;
Garris, Maria ;
McConville, Carmel ;
London, Wendy B. ;
Seeger, Robert C. ;
Grant, Struan F. A. ;
Li, Hongzhe ;
Rahman, Nazneen ;
Rappaport, Eric ;
Hakonarson, Hakon ;
Maris, John M. .
NATURE GENETICS, 2009, 41 (06) :718-723
[9]   HOW FREQUENT IS SPONTANEOUS REMISSION OF NEUROBLASTOMAS - IMPLICATIONS FOR SCREENING [J].
CARLSEN, NLT .
BRITISH JOURNAL OF CANCER, 1990, 61 (03) :441-446
[10]   Surgical risk factors in primary surgery for localized neuroblastoma:: The LNESG1 study of the European International Society of Pediatric Oncology Neuroblastoma Group [J].
Cecchetto, G ;
Mosseri, V ;
De Bernardi, B ;
Helardot, P ;
Monclair, T ;
Costa, E ;
Horcher, E ;
Neuenschwander, S ;
Tomà, P ;
Rizzo, A ;
Michon, J ;
Holmes, K .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (33) :8483-8489